Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study

Am J Hematol. 2020 Jan;95(1):E3-E5. doi: 10.1002/ajh.25651. Epub 2019 Oct 17.

Yishai Ofran^{1

2}, Michal Hayun¹, Ronit Leiba³, Tsila Zuckerman^{1

2}, Netanel Horowitz^{1

2}, Ron Hoffman^{1

2}, Shimrit Ringelstein¹, Noa Lavi^{1

2}, Avraham Frisch¹, Israel Henig¹, Moshe E Gatt⁴, Ilana Hellmann⁵, Ariela Arad⁴, Shlomo Bulvik⁶, Ron Ram⁷, Sharon Gino-Moor⁸, Revital Saban⁴, Ariella Tvito⁹, Jacob M Rowe^{1

2

9}, Chezi Ganzel⁹

¹ Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
² Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.
³ Biostatistics Unit, Rambam Health Care Campus, Haifa, Israel.
⁴ Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
⁵ Hematology Unit, Meir Medical Center, Kfar Saba, Israel.
⁶ Hematology Unit, Sanz Medical Center, Laniado Hospital, Netanya, Israel.
⁷ Hematology Department, Sourasky Medical Center Tel Aviv, Tel Aviv, Israel.
⁸ Department of Hematology, Bnai Zion Medical Center, Haifa, Israel.
⁹ Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.

No abstract available

Publication types